Literature DB >> 15326079

Cardiac metabolism as a target for the treatment of heart failure.

Heinrich Taegtmeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326079     DOI: 10.1161/01.CIR.0000139340.88769.D5

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  62 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

2.  Insulin resistance is not associated with myocardial steatosis in women.

Authors:  M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

Review 3.  Excitation-contraction coupling and mitochondrial energetics.

Authors:  Christoph Maack; Brian O'Rourke
Journal:  Basic Res Cardiol       Date:  2007-07-27       Impact factor: 17.165

4.  The fatty acid beta-oxidation pathway is important for decidualization of endometrial stromal cells in both humans and mice.

Authors:  Jui-He Tsai; Maggie M-Y Chi; Maureen B Schulte; Kelle H Moley
Journal:  Biol Reprod       Date:  2014-02-20       Impact factor: 4.285

5.  Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity.

Authors:  E Madison Sullivan; Amy Fix; Miranda J Crouch; Genevieve C Sparagna; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh
Journal:  J Nutr Biochem       Date:  2017-04-12       Impact factor: 6.048

Review 6.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

7.  Diabetic cardiomyopathy: ongoing controversies in 2012.

Authors:  P M Seferović; I Milinković; A D Ristić; J P Seferović Mitrović; K Lalić; A Jotić; V Kanjuh; N Lalić; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

8.  Treatment of patients with diabetes with GLP-1 analogues or DPP-4- inhibitors: a hot topic for cardiologists?

Authors:  Thomas Jax
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

Review 9.  Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT?

Authors:  Quynh A Truong; Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

10.  Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.

Authors:  Sharad Rastogi; Victor G Sharov; Sudhish Mishra; Ramesh C Gupta; Brent Blackburn; Luiz Belardinelli; William C Stanley; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.